Yunu develops a clinical trial imaging platform that integrates medical imaging data and enhances communication between radiologists and oncologists, facilitating collaboration among study teams, sponsors, and clinical resources. This technology addresses the high error rates in clinical trial imaging, improving data accuracy and accelerating the time-to-market for new therapies.
Funding
$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trials often suffer from high error rates in medical imaging data, leading to inaccurate results and delayed time-to-market for new therapies. Inconsistencies in imaging assessments, stemming from a lack of standardized workflows and inadequate training for radiologists, contribute to these errors. These inaccuracies can misrepresent treatment efficacy and delay drug approval processes by creating incorrect baseline measurements or discrepancies in follow-up imaging.
Solution
Yunu provides a clinical trial imaging platform that integrates medical imaging data and streamlines communication between radiologists, oncologists, and study teams. The platform ensures timely imaging assessments, standardizes processes, and unifies multi-site trials by supporting major response criteria and trial-specific variants. By connecting all sites in a trial and providing visibility to all trials at a site, Yunu enables uniform and simultaneous workflows, accelerating trials and producing more consistent data. The platform also facilitates access to on-demand trial resources and specialists, transforming patient recruitment and diversity by extending trials to a wider range of locations.
Target Audience
Yunu's primary customers include life science companies, cancer centers, sponsors, CROs, imaging CROs, eClinical solution providers, community oncology centers, and pediatric cancer hospitals involved in clinical trials.
Features
- Unified platform for trial management and patient response, providing access to all data across all sites.
- Support for over 30 major response criteria and over 300 trial-specific variants to ensure consistent measurements.
- Real-time review of results and trial performance data via access controls and permission settings.
- Traceable, audit-ready reporting with a full spectrum of real-time reports.
- Streamlined communication between radiologists and oncologists.
- Configurable dashboards overseeing all trials and sites in the operation.
- Role-based access controls and permission settings.